The recurrent glioblastoma cell line with wt p53, GBM10, demonstrated synergistic effects with combination treatment of APX2009 and Napa while the combination was additive in the primary, p53 mutant GBM26 cells (Figure S1C). This evidence concerns the gene NAPA and glioblastoma.